Consolidated Balance Sheets (in millions) |
December 31, 2016 |
December 31, 2015 |
Assets |
|
|
Cash and cash equivalents |
$1,510.8 |
$1,516.6 |
Investments |
4,959.5 |
4,761.8 |
Accounts receivable |
2,687.5 |
2,645.7 |
Property and equipment, net |
1,785.0 |
1,752.2 |
Goodwill and other intangible assets, net |
835.6 |
842.3 |
Other assets |
1,504.4 |
1,626.1 |
Total assets |
$13,282.8 |
$13,144.7 |
Liabilities and Net Assets |
|
|
Claims outstanding |
$2,581.8 |
$2,908.5 |
Unearned premium revenue |
211.9 |
291.9 |
Amounts held for others |
698.3 |
500.7 |
Benefit plan liabilities |
909.7 |
870.1 |
Debt |
1,780.5 |
1,709.8 |
Other liabilities |
1,926.8 |
1,700.1 |
Total liabilities |
8,109.0 |
7,981.1 |
Total net assets |
5,173.8 |
5,163.6 |
Total liabilities and net assets |
$13,282.8 |
$13,144.7 |
Consolidated Statements of Operations (in millions) |
Years Ended December 31, |
2016 |
2015 |
Premium and management services revenue |
$14,420.8 |
$14,116.1 |
Net patient service revenue |
2,004.7 |
1,854.3 |
Vision and other revenue |
1,807.8 |
1,696.5 |
Total unrestricted revenue |
18,233.3 |
17,666.9 |
Claims incurred |
11,148.3 |
11,423.2 |
Depreciation and amortization |
281.8 |
300.2 |
Other operating expense |
6,739.1 |
6,508.5 |
Total operating expenses |
18,169.2 |
18,231.9 |
Operating gain (loss) |
64.1 |
(565.0) |
Net investment income |
166.5 |
294.1 |
Interest expense |
(60.3) |
(60.6) |
Nonoperating (expense) income |
(2.6) |
5.4 |
Excess (deficit) of revenue over expenses before merger |
167.7 |
(326.1) |
Net assets acquired through merger |
- |
249.3 |
Excess (deficit) of revenue over expenses before income taxes |
167.7 |
(76.8) |
Income tax provision |
109.2 |
7.9 |
Excess (deficit) of revenue over expenses |
$58.5 |
$(84.7) |
Consolidated Statements of Cash Flows (in millions) |
Years Ended December 31, |
2016 |
2015 |
Net cash provided by operating activities |
$325.2 |
$22.1 |
Net cash (used in) provided by investing activities |
(380.9) |
478.6 |
Net cash provided by (used in) financing activities |
49.9 |
(92.7) |
(Decrease) increase in cash and cash equivalents |
(5.8) |
408.0 |
Cash and cash equivalents, Beginning of year |
1,516.6 |
1,108.6 |
Cash and cash equivalents, End of year |
$1,510.8 |
$1,516.6 |
|
|
|
Read our financial overview.